Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 10;9(8):886.
doi: 10.3390/vaccines9080886.

COVID-19 Research: Lessons from Non-Human Primate Models

Affiliations
Review

COVID-19 Research: Lessons from Non-Human Primate Models

Laure Albrecht et al. Vaccines (Basel). .

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19). It emerged from China in December 2019 and rapidly spread across the globe, causing a pandemic with unprecedented impacts on public health and economy. Therefore, there is an urgent need for the development of curative treatments and vaccines. In humans, COVID-19 pathogenesis shows a wide range of symptoms, from asymptomatic to severe pneumonia. Identifying animal models of SARS-CoV-2 infection that reflect the clinical symptoms of COVID-19 is of critical importance. Nonhuman primates (NHPss) correspond to relevant models to assess vaccine and antiviral effectiveness. This review discusses the use of NHPs as models for COVID-19 research, with focus on the pathogenesis of SARS-CoV-2 infection, drug discovery and pre-clinical evaluation of vaccine candidates.

Keywords: COVID-19; SARS-CoV-2; drug discovery; non-human primates; pathogenesis; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the clinical, virologic and immunologic features observed over the course of SARS-CoV-2 infection in NHPs. (A) Clinical correlates of SARS-CoV-2 infection in NHPs. (B) SARS-CoV-2 viral kinetics and histopathological changes in the lungs of NHPs. (C) Cytokine production in the lungs of SARS-CoV-2 infected NHPs. (D) Dynamics of innate immune cells in the blood (solid lines) and in the lungs (dashed line). (E) Dynamics of virus-specific antibodies. (F) Dynamics of virus-specific T cells in the blood (solid line) and in the lungs (dashed line). Similar dynamics are observed in SARS-CoV-2 infected individuals. Figure was generated using Inkscape.
Figure 1
Figure 1
Schematic representation of the clinical, virologic and immunologic features observed over the course of SARS-CoV-2 infection in NHPs. (A) Clinical correlates of SARS-CoV-2 infection in NHPs. (B) SARS-CoV-2 viral kinetics and histopathological changes in the lungs of NHPs. (C) Cytokine production in the lungs of SARS-CoV-2 infected NHPs. (D) Dynamics of innate immune cells in the blood (solid lines) and in the lungs (dashed line). (E) Dynamics of virus-specific antibodies. (F) Dynamics of virus-specific T cells in the blood (solid line) and in the lungs (dashed line). Similar dynamics are observed in SARS-CoV-2 infected individuals. Figure was generated using Inkscape.

References

    1. Docea A.O., Tsatsakis A., Albulescu D., Cristea O., Zlatian O., Vinceti M., Moschos S.A., Tsoukalas D., Goumenou M., Drakoulis N., et al. A new threat from an old enemy: Re-emergence of coronavirus (Review) Int. J. Mol. Med. 2020;45:1631–1643. doi: 10.3892/ijmm.2020.4555. - DOI - PMC - PubMed
    1. Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2020 doi: 10.1038/s41579-020-00459-7. - DOI - PMC - PubMed
    1. WHO Coronavirus Disease (COVID-19) Dashboard. [(accessed on 16 April 2021)]; Available online: https://covid19.who.int.
    1. SARS-CoV-2 and Potential Airborne Transmission. [(accessed on 31 March 2021)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov....
    1. Pfefferbaum B., North C.S. Mental Health and the Covid-19 Pandemic. N. Engl. J. Med. 2020;383:510–512. doi: 10.1056/NEJMp2008017. - DOI - PubMed

LinkOut - more resources